Maria Greco

Maria Greco

Auto-generated profile, based on publicly available information

Maria Greco

Ancient Genomics Laboratory, The Francis Crick Institute, NW1 1AT London, United Kingdom

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2011 in Journal of Experimental Botany
Verified
Journal Article
Open access
PDF file
MGMaria Greco
Maria Greco
ACAdriana Chiappetta
Adriana Chiappetta
Leonardo BrunoLeonardo Bruno
Leonardo Bruno
MBMaria Beatrice Antonietta Bitonti
Maria Beatrice Antonietta Bitonti
In mammals, cadmium is widely considered as a non-genotoxic carcinogen acting through a methylation-dependent epigenetic mechanism. Here, the effects of Cd treatment on the DNA methylation patten are examined together with its effect on chromatin reconfiguration in Posidonia oceanica. DNA methylation level and pattern were analysed in actively growing organs, under short- (6 h) and long- (2 d or 4 d) term and low (10 μM) and high (50 μM) doses of Cd, through a Methylation-Sensitive Amplification Polymorphism technique and an immunocytological approach, respectively. The expression of one member of the CHROMOMETHYLASE (CMT) family, a DNA methyltransferase, was also assessed by qRT-PCR. Nuclear chromatin ultrastructure was investigated by transmission electron microscopy. Cd treatment induced a DNA hypermethylation, as well as an up-regulation of CMT, indicating that de novo methylation did indeed occur. Moreover, a high dose of Cd led to a progressive heterochromatinization of interphase nuclei and apoptotic figures were also observed after long-term treatment. The data demonstrate that Cd perturbs the DNA methylation status through the involvement of a specific methyltransferase. Such changes are linked to nuclear chromatin reconfiguration likely to establish a new balance of expressed/repressed chromatin. Overall, the data show an epigenetic basis to the mechanism underlying Cd toxicity in plants.

9 April 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
GAGregorio Alanis-Lobato
Gregorio Alanis-Lobato
JZJasmin Zohren
Jasmin Zohren
AMAfshan McCarthy
Afshan McCarthy
NFNorah M. E. Fogarty
Norah M. E. Fogarty
NKNada Kubikova
Nada Kubikova
KNKathy K. Niakan
Kathy K. Niakan
CRISPR-Cas9 genome editing is a promising technique for clinical applications, such as the correction of disease-associated alleles in somatic cells. The use of this approach has also been discussed in the context of heritable editing of the human germ line. However, studies assessing gene correction in early human embryos report low efficiency of mutation repair, high rates of mosaicism, and the possibility of unintended editing outcomes that may have pathologic consequences. We developed computational pipelines to assess single-cell genomics and transcriptomics datasets from OCT4 ( POU5F1 ) CRISPR-Cas9–targeted and control human preimplantation embryos. This allowed us to evaluate on-target mutations that would be missed by more conventional genotyping techniques. We observed loss of heterozygosity in edited cells that spanned regions beyond the POU5F1 on-target locus, as well as segmental loss and gain of chromosome 6, on which the POU5F1 gene is located. Unintended genome editing outcomes were present in ∼16% of the human embryo cells analyzed and spanned 4–20 kb. Our observations are consistent with recent findings indicating complexity at on-target sites following CRISPR-Cas9 genome editing. Our work underscores the importance of further basic research to assess the safety of genome editing techniques in human embryos, which will inform debates about the potential clinical use of this technology.

27 May 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MGMaria Greco
Maria Greco
Claudio Sáez-AvariaClaudio Sáez-Avaria
Claudio Sáez-Avaria
MBMurray Brown
Murray Brown
MBMaria Beatrice Bitonti
Maria Beatrice Bitonti
The brown seaweed Ectocarpus siliculosus is an emerging model species distributed worldwide in temperate coastal ecosystems. Over 1500 strains of E. siliculosus are available in culture from a broad range of geographic locations and ecological niches. To elucidate the molecular mechanisms underlying its capacity to cope with different environmental and biotic stressors, genomic and transcriptomic studies are necessary; this requires the co-isolation of genomic DNA and total RNA. In brown algae, extraction of nucleic acids is hindered by high concentrations of secondary metabolites that co-precipitate with nucleic acids. Here, we propose a reliable, rapid and cost-effective procedure for the co-isolation of high-quality nucleic acids using small quantities of biomass (25-, 50- and 100 mg) from strains of E. siliculosus (RHO12; LIA4A; EC524 and REP10–11) isolated from sites with different environmental conditions. The procedure employs a high pH extraction buffer (pH 9.5) which contains 100 mM Tris-HCl and 150 mM NaCl, with the addition of 5 mM DTT and 1% sarkosyl to ensure maximum solubility of nucleic acids, effective inhibition of nuclease activity and removal of interfering contaminants (e.g. polysaccharides, polyphenols). The use of sodium acetate together with isopropanol shortened precipitation time and enhanced the yields of DNA/RNA. A phenol:chlorophorm:isoamyl alcohol step was subsequently used to purify the nucleic acids. The present protocol produces high yields of nucleic acids from only 25 mg of fresh algal biomass (0.195 and 0.284 µg mg−1 fresh weigh of RNA and DNA, respectively) and the high quality of the extracted nucleic acids was confirmed through spectrophotometric and electrophoretic analyses. The isolated RNA can be used directly in downstream applications such as RT-PCR and the genomic DNA was suitable for PCR, producing reliable restriction enzyme digestion patterns. Co-isolation of DNA/RNA from different strains indicates that this method is likely to have wider applications for intra- and inter-specific studies on other brown algae.

1 March 2019 in Plant Science
Verified
Journal Article
Closed access
IFIvano Forgione
Ivano Forgione
MWMagdalena Woloszynska
Magdalena Woloszynska
MPMarianna Pacenza
Marianna Pacenza
ACAdriana Chiappetta
Adriana Chiappetta
MGMaria Greco
Maria Greco
Leonardo BrunoLeonardo Bruno
Leonardo Bruno

21 January 2013 in Marine Ecology Progress Series
Verified
Journal Article
Closed access
PDF file
MGMaria Greco
Maria Greco
ACAdriana Chiappetta
Adriana Chiappetta
Leonardo BrunoLeonardo Bruno
Leonardo Bruno
MBMaria Beatrice Antonietta Bitonti
Maria Beatrice Antonietta Bitonti

9 June 2020 in medRxiv
Verified
Preprint
Open access
PDF file
ALAdam G. Laing
Adam G. Laing
ALAnna Lorenc
Anna Lorenc
IBIrene Del Molino Del Barrio
Irene Del Molino Del Barrio
ADAbhishek Das
Abhishek Das
MFMatthew Fish
Matthew Fish
AHAdrian C. Hayday
Adrian C. Hayday
Person-to-person transmission of SARS-CoV-2 virus has triggered a global emergency because of its potential to cause life-threatening Covid-19 disease. By comparison to paucisymptomatic virus clearance by most individuals, Covid-19 has been proposed to reflect insufficient and/or pathologically exaggerated immune responses. Here we identify a consensus peripheral blood immune signature across 63 hospital-treated Covid-19 patients who were otherwise highly heterogeneous. The core signature conspicuously blended adaptive B cell responses typical of virus infection or vaccination with discrete traits hitherto associated with sepsis, including monocyte and dendritic cell dampening, and hyperactivation and depletion of discrete T cell subsets. This blending of immuno-protective and immuno-pathogenic potentials was exemplified by near-universal CXCL10/IP10 upregulation, as occurred in SARS1 and MERS. Moreover, specific parameters including CXCL10/IP10 over-expression, T cell proliferation, and basophil and plasmacytoid dendritic cell depletion correlated, often prognostically, with Covid-19 progression, collectively composing a resource to inform SARS-CoV-2 pathobiology and risk-based patient stratification.